|
⚲
|
| Keyboard |
| Sarah Romano | |
|---|---|
| Firm | Goldman Sachs Asset Management LP |
| Address | 78 Fourth Avenue Waltham, MA 02451 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Goldman Sachs Asset Management LP | |||||
| Des MSF Holdings LLC | 021-560942 | Executive Officer | 11.7 M of 11.7 M |
17.3 M | |
| First Wave Biopharma Inc | 021-492736 | Executive Officer | 1.5 M of 1.5 M |
||
| First Wave Biopharma Inc | 021-485434 | Executive Officer | 0.4 M of 0.4 M |
||
| First Wave Biopharma Inc | 021-476784 | Executive Officer | 4.0 M of 4.0 M |
||
| First Wave Biopharma Inc | 021-466316 | Executive Officer | 2.5 M of 2.5 M |
||
| First Wave Biopharma Inc | 021-453813 | Executive Officer | 0.3 M of 0.3 M |
||
| Eyegate Pharmaceuticals Inc | 021-419911 | Executive Officer | 0.1 M | ||
| Eyegate Pharmaceuticals Inc | 021-410958 | Executive Officer | 10.8 M of 10.8 M |
||
| Eyegate Pharmaceuticals Inc | 021-386998 | Executive Officer | 8.0 M of 8.0 M |
||
| Eyegate Pharmaceuticals Inc | 021-385028 | Executive Officer | 3.2 M | ||
| Eyegate Pharmaceuticals Inc | 021-358165 | Executive Officer | |||
| Eyegate Pharmaceuticals Inc | 021-350635 | Executive Officer | 1.9 M of 1.9 M |
||